Takeda acquiring Inviragen

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will acquire infectious disease company Inviragen Inc. (Fort Collins. Colo.) for $35 million in cash up front, plus up to $215 million in milestones. Invira...